Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis

Oncology Reports

Volumn 24, Issue 2, 2010, Pages 495-500

  Tang, Can E ^a   Tan, Tan ^b   Li, Cui ^a   Chen, Zhu Chu ^a   Ruan, Lin ^a   Wang, Hong Han ^a   Su, Tao ^a   Zhang, Peng Fei ^a   Xiao, Zhi Qiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

Author keywords

Biomarker; Galectin 1; Nasopharyngeal carcinoma; Proteomics

Indexed keywords

GALECTIN 1; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; AMINO ACID SEQUENCE; CARCINOMA; GENETICS; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; NASOPHARYNGEAL NEOPLASMS; PHYSIOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; CARCINOMA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GALECTIN 1; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 77954364289     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000884     Document Type: Article

References (22)

1. Yu MC and Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429, 2002.
2. McDermott AL, Dutt SN and Watkinson JC: The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci 26: 82-92, 2001.
3. Wong MM, Lye MS, Cheng HM and Sam CK: Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma. Asian Pac J Allergy Immunol 23: 65-67, 2005. (Pubitemid 40790090)
4. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Peng F, Duan CJ and Xiao ZQ: Identification of cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res 7: 2415-2426, 2008.
5. Cheng AL, Huang WG, Chen ZC, Peng F, Zhang PF, Li MY, Li F, Li JL, Li C, Yi H, Yi B and Xiao ZQ: Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res 14: 435-445, 2008.
6. Diamandis EP: Identification of serum amyloid a protein as a potentially useful biomarker for nasopharyngeal carcinoma. Clin Cancer Res 10: 5293-5294, 2004.
7. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V and Zeng YX: Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 66: 6225-6232, 2006.
8. Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande WG, Resau JH and Teh BT: Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 62: 589-596, 2002.
9. Sriuranpong V, Mutirangura A, Gillespie JW, Patel V, Amornphimoltham P, Molinolo AA, Kerekhanjanarong V, Supanakorn S, Supiyaphun P, Rangdaeng S, Voravud N and Gutkind JS: Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res 10: 4944-4958, 2004.
10. Li C, Xiao Z, Chen Z, Zhang X, Li J, Wu X, Li X, Yi H, Li M, Zhu G and Liang S: Proteome analysis of human lung squamous carcinoma. Proteomics 6: 547-558, 2006.
11. Yang F, Xiao ZQ, Zhang XZ, Li C, Zhang PF, Li MY, Chen Y, Zhu GQ, Sun Y, Liu YF and Chen ZC: Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J Proteome Res 6: 751-758, 2007.
12. McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA and Gittoes NJ: Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol 58: 141-150, 2003.
13. Chen Y, Tang CE, Ouyang GL, Ruan L, Li MY, Zhang PF, Li C, Yi H, Peng F, Li JL, Chen ZC and Xiao ZQ: Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach. Med Oncol 26: 463-470, 2009.
14. Reymond MA and Schlegel W: Proteomics in cancer. Adv Clin Chem 44: 103-142, 2007.
15. Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F and Kiss R: Anti-galectin compounds as potential anticancer drugs. Curr Med Chem 13: 3513-3527, 2006.
16. Camby I, Le MM, Lefranc F and Kiss R: Galectin-1: a small protein with major functions. Glycobiology 16: R137-R157, 2006.
17. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, Andre S, Gabius HJ, Khachigian L, Detjen KM and Rosewicz S: Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 280: 37266-37277, 2005.
18. Elad-Sfadia G, Haklai R, Ballan E, Gabius HJ and Kloog Y: Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J Biol Chem 277: 37169-37175, 2002.
19. Szoke T, Kayser K, Baumhakel JD, Trojan I, Furak J, Tiszlavicz L, Horvath A, Szluha K, Gabius HJ and Andre S: Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer. Oncology 69: 167-174, 2005. (Pubitemid 41376916)
20. Grutzmann R, Pilarsky C, Ammerpohl O, Luttges J, Bohme A, Sipos B, Foerder M, Alldinger I, Jahnke B, Schackert HK, Kalthoff H, Kremer B, Kloppel G and Saeger HD: Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6: 611-622, 2004.
21. Shen J, Person MD, Zhu J, Abbruzzese JL and Li D: Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64: 9018-9026, 2004.
22. Gabius HJ, Andre S, Gunsenhauser I, Kaltner H, Kayser G, Kopitz J, Lahm H, Harms D, Szymas J and Kayser K: Association of galectin-1- but not galectin-3-dependent parameters with proliferation activity in human neuroblastomas and small cell lung carcinomas. Anticancer Res 22: 405-410, 2002. (Pubitemid 34475330)